A prospective, multicenter, randomized, double-blind trial of IV ibuprofen for treatment of fever and pain in burn patients

Journal of Burn Care and Research

Volumn 32, Issue 1, 2011, Pages 79-90

  Promes, John T ^a   Safcsak, Karen ^a   Pavliv, Leo ^b   Voss, Bryan ^b   Rock, Amy ^b  

^a ORLANDO REGIONAL MEDICAL CENTER   (United States)

^b Cumberland Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FAMOTIDINE; IBUPROFEN; METOCLOPRAMIDE; PLACEBO; RANITIDINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANEMIA; ARTICLE; BODY TEMPERATURE; BURN; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FEVER; GASTROINTESTINAL DISEASE; HEMATOCRIT; HUMAN; HYPERCHLOREMIA; HYPERNATREMIA; HYPOTENSION; INFECTION; INFESTATION; INJECTION SITE REACTION; INTERNATIONAL NORMALIZED RATIO; KIDNEY DISEASE; LABORATORY TEST; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MULTICENTER STUDY; PAIN; PAIN ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECOMMENDED DRUG DOSE; SEPTIC SHOCK; SEPTICEMIA; SIDE EFFECT; TACHYPNEA; TREATMENT OUTCOME; URINARY TRACT DISEASE; VERBAL RESPONSE SCALE; VISUAL ANALOG SCALE; VITAL SIGN;

ADULT; AREA UNDER CURVE; BURNS; DOUBLE-BLIND METHOD; FEMALE; FEVER; HUMANS; IBUPROFEN; INFUSIONS, INTRAVENOUS; MALE; PAIN; PAIN MEASUREMENT; PLACEBOS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79151476199     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3182037300     Document Type: Article

References (31)

1. American Burn Association. Burn incidence and treatment in the U.S.: 2007 Fact Sheet. Chicago, IL: American Burn Association; 2007.
2. American Burn Association/American College of Surgeons. Guidelines for the operation of burn centers. J Burn Care Res. 2007;28:134-41.
3. Connor-Ballard PA. Understanding and managing burn pain: part 2. Am J Nurs 2009;109:54-62; quiz 63.
4. Dissanaike S, Rahimi M. Epidemiology of burn injuries: highlighting cultural and socio-demographic aspects. Int Rev Psychiatry 2009;21:505-11.
5. Keck M, Herndon DH, Kamolz LP, Frey M, Jeschke MG. Pathophysiology of burns. Wien Med Wochenschr 2009; 159:327-36.
6. Wilmore DW, Aulick LH. Metabolic changes in burned patients. Surg Clin North Am 1978;58:1173-87.
7. Frankenfield DC, Smith JS Jr, Cooney RN, Blosser SA, Sarson GY. Relative association of fever and injury with hypermetabolism in critically ill patients. Injury 1997;28:617-21.
8. Williams FN, Herndon DN, Jeschke MG. The hypermetabolic response to burn injury and interventions to modify this response. Clin Plast Surg 2009;36:583-96.
9. Latenser BA. Critical care of the burn patient: the first 48 hours. Crit Care Med 2009;37:2819-26.
10. Hanson DF. Fever, temperature, and the immune response. Ann N Y Acad Sci 1997;813:453-64.
11. Gore DC, Chinkes D, Sanford A, Hart DW, Wolf SE, Herndon DN. Influence of fever on the hypermetabolic response in burn-injured children. Arch Surg 2003;138:169-74; discussion 174.
12. Nguyen TT, Gilpin DA, Meyer NA, Herndon DN. Current treatment of severely burned patients. Ann Surg 1996;223: 14-25.
13. Laupland KB. Fever in the critically ill medical patient. Crit Care Med 2009;37(7 suppl):S273-S278.
14. Marvin JA, Miller MJ, Blakeney PE, Meyer WJ III. Pain response and pain control. London: WB Saunders; 1996.
15. Ulmer JF. Burn pain management: a guideline-based approach. J Burn Care Rehabil 1998;19:151-159.
16. Waymack JP, Jenkins M, Gottschlich M, Alexander JW, Warden GD. Effect of ibuprofen on the postburn hypermetabolic response: a case report. J Burn Care Rehabil 1990;11: 340-42.
17. Wallace BH, Caldwell FT Jr, Cone JB. Ibuprofen lowers body temperature and metabolic rate of humans with burn injury. J Trauma 1992;32:154-7.
18. Choiniere M. Burn pain: a unique challenge. International Association for the Study of Pain. 2001;9(1).
19. Mavrogordato AE, Wagstaff MJ, Fletcher AJ, Wilson DI, Jayamaha JE. A novel method to treat hyperthermia in a burns case: use of a catheter-based heat exchange system. Burns 2009;35:141-5.
20. Sawchuk RJ, Rector TS. Drug kinetics in burn patients. Clin Pharmacokinet 1980;5:548-56.
21. Cone JB, Wallace BH, Olsen KM, Caldwell FT Jr, Gurley BJ, Bond PJ. The pharmacokinetics of ibuprofen after burn injury. J Burn Care Rehabil 1993;14:666-9.
22. Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 1997;336:912-8.
23. Southworth S, Peters J, Rock A, Pavliv L. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Clin Ther 2009;31:1922-35.
24. Krudsood S, Tangpukdee N, Wilairatana P, et al. Intravenous ibuprofen (IV-ibuprofen) controls fever effectively in adults with acute uncomplicated Plasmodium falciparum malaria but prolongs parasitemia. Am J Trop Med Hyg 2010;83: 51-5.
25. Singla N, Rock A, Pavliv L. A multi-center, randomized, double-blind placebo-controlled trial of intravenousibuprofen (IV-ibuprofen) for treatment of pain in postoperative orthopedic adult patients. Pain Med 2010;11: 1284-93.
26. Kroll PB, Meadows L, Rock A, Pavliv L. A multi-center, randomized, double-blind placebo-controlled trial of intravenous ibuprofen (IV-ibuprofen) in the management of postoperative pain following abdominal hysterectomy. Pain Pract. [Epub ahead of print July, 2010].
27. Morris PE, Promes JT, Guntupalli KK, Wright PE, Arons MM. A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults. Crit Care 2010;14:R125.
28. Caldolor (ibuprofen) injection [product labeling]. Nashville, TN: Cumberland Pharmaceuticals, Inc.; 2009.
29. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
30. Youn YK, LaLonde C, Demling R. The role of mediators in the response to thermal injury. World J Surg 1992;16:30-6.
31. Bookstaver PB, Miller AD, Rudisill CN, et al. Intravenous ibuprofen: the first injectable product for treatment of pain and fever. J Pain Res 2010;3:67-79.